首页> 外文期刊>Thoracic cancer. >Efficacy and safety of artificial pneumothorax with position adjustment for CT‐guided percutaneous transthoracic microwave ablation of small subpleural lung tumors
【24h】

Efficacy and safety of artificial pneumothorax with position adjustment for CT‐guided percutaneous transthoracic microwave ablation of small subpleural lung tumors

机译:人工气胸与CT引导的经皮肺肿瘤微波消融的位置调整的疗效和安全性

获取原文
获取外文期刊封面目录资料

摘要

To evaluate the efficacy and safety of artificial pneumothorax with position adjustment for computed tomograpy (CT)-guided percutaneous transthoracic microwave ablation (MWA) of small subpleural lung tumors. Fifty-six patients with small subpleural lung tumors ( 3.0 cm) entered the study and underwent CT-guided MWA with (group I: 24 patients with 24 tumors) or without (group II: 32 patients with 34 tumors) the support of artificial pneumothorax. Follow-up contrast-enhanced CT scans were reviewed. Pain VAS (visual analog scale) scores at, during, and after ablation were compared between the two groups. Technical success, technique efficacy, local tumor control and complications were compared. Creation of the artificial pneumothorax was achieved for 24/24 (100%) in group I and no complication related to the procedure was observed. Technical success of MWA was achieved for all 58 tumors. Primary efficacy of MWA was achieved in 23 of 24 tumors (95.8%) treated in group I, and 32 of 34 tumors (94.1%) treated in group II (P = 0.771). The 12-month local tumor control was achieved in 87.5% (21/24) in group I compared with 88.2% (30/34) in group II (P = 0.833). Pain VAS scores in group I were significantly decreased after the pneumothorax induction at, during, and after ablation compared with group II (P??0.05). Artificial pneumothorax with position adjustment for CT-guided MWA is effective and may be safely applied to small subpleural lung tumors. Artificial pneumothorax is a reliable therapy for pain relief. ? 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:为了评估人工气胸的功效和安全性与计算的分枝瘤(CT) - 中小肺肿瘤的经皮静脉微波烧蚀(MWA)的位置调整。五十六名小副肺肿瘤患者(<3.0厘米)进入了研究和接受了CT引导的MWA(第I族:24例24例24例肿瘤患者)或没有(第三组:32例患者34例肿瘤)人工的支持气胸。审查了跟进对比度增强的CT扫描。在两组之间比较了疼痛VAS(视觉模拟规模)分数,期间和在两组之间进行消融。技术成功,技术疗效,局部肿瘤对照和并发症进行了比较。在I组中的24/24(100%)达到人造气胸的产生,并且没有观察到与该程序相关的并发症。所有58个肿瘤都达到了MWA的技术成功。 MWA的初级疗效在第I族的24个肿瘤(95.8%)中获得的23个,II族治疗中的32个肿瘤(94.1%)(p = 0.771)。在I基团的87.5%(21/24)中,将12个月的局部肿瘤对照组成,而II族的88.2%(30/34)(p = 0.833)。在与II族(Pα0)相比,在粘合期间和后,在嗜血素诱导后,I型疼痛VAS评分在嗜血素诱导后显着降低(P ?? 0.05)。具有CT引导MWA的位置调节的人工气胸是有效的,可以安全地应用于小副肺肿瘤。人工气胸是一种可靠的疼痛缓解疗法。 ? 2019年的作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号